| Mepha Pharma AG - Sitagliptin-Metformin-Mepha 50/850 mg, Filmtabletten | | 68378 | | 02 | | Sitagliptin-Metformin-Mepha 50/850 mg | | Filmtabletten | | A10BD07 | | Metformin and Sitagliptin | | 05.04.2022 | | |
| | Composition | | metformini hydrochloridum 850 mg, sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, povidonum K 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: copolymerum macrogolo et alcoholi poly(vinylico) constatum, talcum, glyceroli monocaprylocapras, poly(alcohol vinylicus), E 171, E 172 (rubrum), pro compresso obducto corresp. natrium 1.74 mg. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Metformin Hydrochloride | 850 mg | | Sitagliptine | 50 mg |
| | BAG: Active Agent | Dose |
|---|
| Metformin Hydrochloride | 850 mg | | Sitagliptine | 50 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Rubrum) | | | | Cellulosum Microcristallinum | | | | Copolymerum Macrogolo et Alcoholi Poly(Vinylico) Constatum | | Überzug | | E 171 | | color. | | E 172 | | color. | | Glyceroli Monocaprylocapras | | | | Natrii Laurilsulfas | | | | Natrii Stearylis Fumaras | | | | Poly(Alcohol Vinylicus) | | | | Povidonum K | 29-32 | | | Pro Compresso Obducto | | | | Talcum | | |
| |
| |
|
